Abstract Background: Negative Symptoms (blunted affect, alogia, anhedonia, avolition and
asociality) are observed in schizophrenia but also in depressive disorders. Objective: To …

Background Disrupted metacognition is implicated in development and maintenance of
negative symptoms, but more fine‐grained analyses would inform precise treatment …

Anhedonia and amotivation are debilitating symptoms and represent unmet therapeutic
needs in a range of clinical conditions. The gut-microbiome-endocannabinoid axis might …

Background Research suggests that effort-cost decision-making (ECDM), the estimation of
work required to obtain reward, may be a relevant framework for understanding motivational …

Patients with schizophrenia perform worse on neuropsychological tasks than controls. While
most experts ascribe poor performance to neurocognitive impairment, an emerging literature …

Background Negative symptoms (NS) may be observed in the general population in an
attenuated form and in high-risk mental states. However, they have been less studied in the …

Earlier recognition and accurate assessment of depressive symptoms is important to
improving outcomes in individuals with recent-onset schizophrenia spectrum disorders …

Abstract Background Negative Symptoms (blunted affect, alogia, anhedonia, avolition, and
asociality) are usually described in schizophrenia but they are also present in other …

To mitigate the often chronic course of schizophrenia and improve functional outcome,
researchers are increasingly interested in prodromal states and psychological risk factors …

Negative symptoms in schizophrenia show striking similarities to some depressive
symptoms. Different terms are often used for these phenomenologically similar symptoms …